Cancer Detection

Metformin use is associated with reduced cancer risk

April 25, 2024 - Two recent studies published in the Journal of the National Cancer Institute have correlated metformin use with lower cancer risks, implying that the drug may offer some protection against the illness. The first of these studies was a systematic review and meta-analysis published earlier this year. Researchers used databases such as PubMed,...

Read More


More Articles

Evaluating the Breast Cancer Therapeutics Market

by Veronica Salib

As breast cancer awareness month continues, gathering a comprehensive understanding of the breast cancer therapeutics market is critical, including current trends and market players, gaps, and predictions for the coming year. Understanding...

FDA Launches Programs to Reduce Risk of Cancer Biomarker Testing

by Veronica Salib

Last week, on June 20, 2023, the United States Food and Drug Administration (FDA) launched a pilot program to reduce the risk of laboratory-developed tests to identify cancer biomarkers. The program...

FDA-Approved Cell Therapy Protects Patients After Stem Cell Transplant

by Veronica Salib

The FDA recently approved Omisirge (omidubicel-onlv), a new cell therapy meant to protect patients with blood cancer after a stem cell transplant. According to the press release, the treatment can...

HHS Releases National Cancer Plan to Further Cancer Moonshot

by Veronica Salib

On April 3, 2023, the United States HHS released detailed information for a National Cancer Plan. The plan aims to facilitate the Cancer Moonshot initiative. The Biden administration reignited the...

Nectin Therapeutics Collaborates with Merck on Cancer Treatment

by Veronica Salib

Earlier this year, Nectin Therapeutics Ltd, a clinical biotechnology company, announced a collaboration with Merck, a leading global pharmaceutical company, to develop a treatment regimen for cancer patients. The clinical trial combines a...

Phase 1 Clinical Trial Achieves Leukemia Remission in 18 Patients

by Veronica Salib

In a study published in Nature on March 15, 2023, researchers achieved complete or nearly complete remission in 18 patients with KMT2A-rearranged or NPMI-mutant leukemia. The phase 1 clinical trial...

Washington State Takes Regulatory Steps Toward Non-Toxic Cosmetics

by Veronica Salib

In House Bill 1047 — introduced on January 9, 2023, and sponsored by representative Sharlett Mena — Washington state has begun to take regulatory steps toward non-toxic cosmetics. The bill...

FDA Awards 19 Grants for Rare Disease Research

by Veronica Salib

On October 17, 2022, the FDA announced that its Orphan Products Grants Program has awarded 19 grants and 2 contracts, amounting to over $38 million, for rare disease research. This action will...

How Chemotherapy Drugs Impact Cells, Patients, and the Healthcare System

by Veronica Salib

Chemotherapy drugs play a significant role in the treatment of cancer. Understanding the kinds of chemotherapy drugs can help patients make an informed decision with the assistance of their oncologist and their team of healthcare...

FDA Proposes Ban on All Flavored Cigarettes, Cigars

by Hayden Schmidt

Today, the FDA is proposing a total ban on flavored cigarettes and cigars, citing their link to increased rates of addiction in young people and their elevated risk of enhanced effects on the...

Recent Articles